At close: December 20 at 4:00:02 PM EST
After hours: December 20 at 6:56:56 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-45,927.0000
-33,448.0000
-20,394.0000
-9,262.0000
Investing Cash Flow
-1,921.0000
-470.0000
-732.0000
-680.0000
Financing Cash Flow
178,774.0000
68,130.0000
43,789.0000
31,688.0000
End Cash Position
182,214.0000
82,548.0000
48,344.0000
25,705.0000
Interest Paid Supplemental Data
998.0000
912.0000
--
--
Capital Expenditure
-1,921.0000
-470.0000
-732.0000
-680.0000
Issuance of Capital Stock
182,760.0000
70,181.0000
34,305.0000
31,893.0000
Issuance of Debt
--
--
9,825.0000
--
Free Cash Flow
-47,848.0000
-33,918.0000
-21,126.0000
-9,942.0000
12/31/2021 - 2/2/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AVBP ArriVent BioPharma, Inc.
26.09
+1.72%
KYTX Kyverna Therapeutics, Inc.
4.0000
+3.36%
BOLD Boundless Bio, Inc.
2.5900
+2.78%
LXEO Lexeo Therapeutics, Inc.
6.28
+3.97%
SPRB Spruce Biosciences, Inc.
0.4000
+4.68%
PEPG PepGen Inc.
3.6300
-11.25%
GUTS Fractyl Health, Inc.
1.7900
-1.65%
MGNX MacroGenics, Inc.
3.1800
0.00%
DSGN Design Therapeutics, Inc.
6.25
+4.34%
VIGL Vigil Neuroscience, Inc.
1.7000
+2.41%